597 Results

People

  1. Saltz
    Saltz
  2. O'Reilly
    O'Reilly
  3. D'Angelica
    D'Angelica
  4. Jarnagin
    Jarnagin
  5. Kemeny
    Kemeny
  6. Lichtman
    Lichtman
  7. Fong
    Fong
  8. Gonen
    Gonen
  9. Ilson
    Ilson
  10. Kingham
    Kingham

Groups

  1. Department of Medicine (407)
  2. Solid Tumor Oncology Division (372)
  3. Gastrointestinal Oncology Service (293)
  4. Center for Pancreatic Cancer Research (179)
  5. Surgery (167)
  6. Epidemiology and Biostatistics (76)
  7. Survivorship Research (76)
  8. Biostatistics Service (68)
  9. Population Sciences Research Program (63)
  10. Colorectal Surgery (59)
  1. "oxaliplatin"
Formats
  1. Journal Article (538)
  2. Review (36)
  3. Editorial (11)
  4. Correspondence (3)
  5. Conference Paper (2)
  6. Meeting Abstract (2)
  7. Miscellaneous (2)
  8. Book Section (1)
  9. Guidelines (1)
  10. Research Letter (1)
Groups
  1. Department of Medicine (407)
  2. Solid Tumor Oncology Division (372)
  3. Gastrointestinal Oncology Service (293)
  4. Center for Pancreatic Cancer Research (179)
  5. Surgery (167)
  6. Epidemiology and Biostatistics (76)

More Groups

People
  1. Leonard Saltz (84)
  2. Nancy Kemeny (74)
  3. Eileen O'Reilly (64)
  4. Michael D'Angelica (51)
  5. William Jarnagin (49)
  6. Stuart Lichtman (45)

More People

Years
  1. 2025 (20)
  2. 2024 (55)
  3. 2023 (33)
  4. 2022 (27)
  5. 2021 (13)
  6. 2020 (17)

More Years

Publications
  1. Journal of Clinical Oncology (42)
  2. Annals of Surgical Oncology (38)
  3. Journal of the National Comprehensive Cancer Network (29)
  4. The Oncology Report (26)
  5. Annals of Oncology (16)
  6. Cancer (16)

More Publications

Publishers
  1. Elsevier Inc. (99)
  2. Springer (75)
  3. American Society of Clinical Oncology (46)
  4. Oxford University Press (40)
  5. Wiley Blackwell (33)
  6. Elsevier Science, Inc. (29)

More Publishers

Results (597)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Identifying participants’ preferences for modifiable chemotherapy-induced peripheral neuropathy prevention clinical trial factors: An adaptive choice-based conjoint analysis
    Journal Article

    Knoerl, R.; Berry, D.; Meyerhardt, J. A.; Reyes, K.; Salehi, E.; Thornton, K.; Gewandter, J. S.
    Supportive Care in Cancer (2022)

    Fulltext@MSK | Save
  • Successful brentuximab vedotin and nivolumab therapy of multiply refractory diffuse large B-cell lymphoma with Hodgkin features
    Correspondence

    Zibara, V.; Sen, F.; Scordo, M.; Falchi, L.
    Leukemia and Lymphoma (2022)

    Fulltext@MSK | Save
  • Neo-adjuvant FOLFIRINOX in borderline resectable and locally advanced pancreatic adenocarcinoma
    Journal Article

    Temraz, S.; Nassar, F.; Hammoud, M. S.; Mukherji, D.; O'Reilly, E. M.; Dbouk, H.; Farhat, F.; Charafeddine, M.; Faraj, W.; Khalifeh, M. J.; more...
    Asia-Pacific Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Pooled safety analysis from phase III studies of trifluridine/tipiracil in patients with metastatic gastric or gastroesophageal junction cancer and metastatic colorectal cancer
    Journal Article

    Van Cutsem, E.; Hochster, H.; Shitara, K.; Mayer, R.; Ohtsu, A.; Falcone, A.; Yoshino, T.; Doi, T.; Ilson, D. H.; Arkenau, H. T.; more...
    ESMO Open (2022)

    Fulltext@MSK | Save
  • Effect of FGFR2 alterations on overall and progression-free survival in patients receiving systemic therapy for intrahepatic cholangiocarcinoma
    Journal Article

    Abou-Alfa, G. K.; Bibeau, K.; Schultz, N.; Yaqubie, A.; Millang, B.; Ren, H.; Féliz, L.
    Targeted Oncology (2022)

    Fulltext@MSK | Save
  • A proliferative subtype of colorectal liver metastases exhibits hypersensitivity to cytotoxic chemotherapy
    Journal Article

    Spurr, L. F.; Martinez, C. A.; Katipally, R. R.; Iyer, S. C.; Pugh, S. A.; Bridgewater, J. A.; Primrose, J. N.; Domingo, E.; Maughan, T. S.; D’Angelica, M. I.; more...
    npj Precision Oncology (2022)

    Fulltext@MSK | Save
  • A dynamic clinical calculator for estimating conditional recurrence-free survival after total neoadjuvant therapy for rectal cancer and either surgery or watch-and-wait management
    Journal Article

    Weiser, M. R.; Chou, J. F.; Kim, J. K.; Widmar, M.; Wei, I. H.; Pappou, E. P.; Smith, J. J.; Nash, G. M.; Paty, P. B.; Cercek, A.; more...
    JAMA Network Open (2022)

    Fulltext@MSK | Save
  • Improved efficacy of tafasitamab plus lenalidomide versus systemic therapies for relapsed/refractory DLBCL: RE-MIND2, an observational retrospective matched cohort study
    Journal Article

    Nowakowski, G. S.; Yoon, D. H.; Peters, A.; Mondello, P.; Joffe, E.; Fleury, I.; Greil, R.; Ku, M.; Marks, R.; Kim, K.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • Neoadjuvant radiotherapy after (m)FOLFIRINOX for borderline resectable pancreatic adenocarcinoma: A TAPS Consortium study
    Journal Article

    Janssen, Q. P.; van Dam, J. L.; Prakash, L. R.; Doppenberg, D.; Crane, C. H.; van Eijck, C. H. J.; Ellsworth, S. G.; Jarnagin, W. R.; O'Reilly, E. M.; Paniccia, A.; more...
    Journal of the National Comprehensive Cancer Network (2022)

    Fulltext@MSK | Save
  • Alterations in somatic driver genes are associated with response to neoadjuvant FOLFIRINOX in patients with localized pancreatic ductal adenocarcinoma
    Journal Article

    Ecker, B. L.; Court, C. M.; Janssen, Q. P.; Tao, A. J.; D'Angelica, M. I.; Drebin, J. A.; Gonen, M.; O'Reilly, E. M.; Jarnagin, W. R.; Wei, A. C.; more...
    Journal of the American College of Surgeons (2022)

    Fulltext@MSK | Save